🔎 Trials Near Me

Hjem › Kreft (alle typer) › Indiana › Indianapolis

Kliniske studier for Kreft (alle typer) i Indianapolis, IN

24 studier for Kreft (alle typer) søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Daily Hand-Held Vibration Therapy

Rekrutterer
  • Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
  • IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
  • Indiana University Health West, Avon · 13 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT04207437

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RekruttererObservasjonsstudie
  • Indiana University, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05874921

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

RekruttererFase 3
  • Franciscan Health Oncology and Hematology Specialists, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

RekruttererFase 3
  • Franciscan St. Francis Health /ID# 279788, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

RekruttererFase 2
  • Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RekruttererFase 1/2
  • Community Health Network, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RekruttererFase 2/3
  • IN Univ Simon Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03435796

Collection of Tissue Samples for Cancer Research

RekruttererObservasjonsstudie
  • Indiana University - Purdue, Indianapolis
2 Months · Alle kjønn · Oppdatert 16. sep. 2026 · NCT00900198

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

RekruttererFase 2
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07169851

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • Riley Hospital for Children, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

RekruttererFase 3
  • Franciscan Health, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05335928

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RekruttererFase 3
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06580314

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 1
  • Franciscan St. Francis Health /ID# 280928, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT05650632

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

RekruttererFase 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT05852717

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

RekruttererFrivillige helsepersonell ønskes velkommen
  • Indiana University School of Medicine, Indianapolis
Alder 18 til 99 · Alle kjønn · Oppdatert 24. jun. 2026 · NCT05346796

Childhood Cancer Survivor Study

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Indiana University/Riley Hospital for Children, Indianapolis
Alle aldre · Alle kjønn · Oppdatert 17. jun. 2026 · NCT01120353

Galleri® in the Medicare Population.

RekruttererFrivillige helsepersonell ønskes velkommen
  • Community Health Network East, Indianapolis
  • Community Health Network South, Indianapolis
Alder 50 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT05673018

The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities

Rekrutterer
  • University Hospital Clinical Research Center, Indianapolis
Alder 45 til 75 · Alle kjønn · Oppdatert 14. mai 2026 · NCT07086833

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Rekrutterer
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 19. feb. 2026 · NCT02984761

GEMINI-NSCLC: NSCLC Biomarker Study

RekruttererObservasjonsstudie
  • Community Health Network, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT05236114

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • IU Simon Comprehensive Cancer Center, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 18. mai 2025 · NCT05970497

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

RekruttererFase 1/2
  • Community Health Network, Inc., Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

Kreft (alle typer)-studier i andre byer

Andre studier i Indianapolis

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.